Supreme court rejects Nebraska and Oklahoma lawsuit over Colorado marijuana legalisation

News

Supreme court rejects Nebraska and Oklahoma lawsuit over Colorado marijuana legalisation

23 March 2016

Today, the United States Supreme Court declined to hear the case brought by Nebraska and Oklahoma against Colorado over its marijuana legalization law. Oklahoma and Nebraska had claimed the Colorado law had created an increased law enforcement burden in neighboring states. The suit, filed by Nebraska Attorney General John Bruning and Oklahoma Attorney General Scott Pruitt, claimed that federal marijuana prohibition preempts the law that Colorado voters decisively adopted in 2012. The Federal Government filed a brief urging the high court to reject the case.

Statement from Tamar Todd, Director, Office of Legal Affairs of the Drug Policy Alliance:

“The Supreme Court’s rejection of this misguided effort to undo cautious and effective state-level regulation of marijuana is excellent news for the many other states looking to adopt similar reforms in 2016 and beyond. Other states are looking to what Colorado has accomplished: the drops in racially disparate arrests, the criminal justice dollars saved, and the tax revenue raised and want to adopt similar marijuana law reforms. The dismissal of this action means that the four states that have adopted ballot initiatives by decisive margins to tax and regulate marijuana for adults, as well as the many states that have adopted laws to regulate medical marijuana, can proceed without interference at this time.

“The Federal government itself filed a brief with the high court asking that it not hear this case. It has not challenged the regulatory law in Colorado nor did it choose to interfere with its implementation. To the contrary, the government has deprioritized enforcement of state-level marijuana reforms and acknowledged the interests that both states and the Federal government have in openly regulating marijuana.”

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Wikipedia